What Is BPC-157? A Complete Research Introduction
Research Use Only: This content is intended for educational and research purposes only. BPC-157 is not approved by the FDA for human use. Not for human or veterinary consumption. For laboratory research use only.
What Is BPC-157? The Science Behind the Body Protection Compound Peptide
BPC-157 is a synthetic pentadecapeptide — a chain of exactly 15 amino acids — derived from a protective protein found in human gastric juice. It has been studied extensively in preclinical and animal research models since the early 1990s, making it one of the most researched peptides in the field of regenerative biology. It is not approved by the FDA for human use and is sold strictly as a research compound.
Researchers sourcing this compound can find BPC-157 research peptide at Palmetto Peptides, available as a ≥98% purity, COA-verified peptide for preclinical laboratory use.
If you have come across BPC-157 in scientific literature, research forums, or peptide catalogs and want to understand what it actually is at a molecular level, this article covers the fundamentals: its origin, structure, primary mechanisms studied in preclinical settings, and its current regulatory standing.
> Research use only. All information in this article pertains to preclinical and animal model research. BPC-157 is not approved by the FDA for human use and is not intended for human consumption. Palmetto Peptides supplies BPC-157 exclusively for laboratory and research purposes.
What Does BPC Stand For?
BPC stands for Body Protection Compound. The "157" refers to its sequence — it is the 157th fragment studied from the parent gastric protein from which it was isolated. The full scientific name is gastric pentadecapeptide BPC-157, and it is also referenced in the literature under the names bepecin and PL 14736.
The peptide was first isolated and characterized by a research group led by Dr. Predrag Sikiric at the University of Zagreb School of Medicine in Croatia. Their earliest published work appeared in the mid-1990s, and the compound has since accumulated a substantial body of preclinical literature spanning over 30 years.
The Molecular Structure of BPC-157
BPC-157 is a linear peptide — meaning it has no disulfide bonds — composed of 15 amino acids in the following sequence:
Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val| Property | Value | |---|---| | Molecular formula | C₆₂H₉₈N₁₆O₂₂ | | Molecular weight | ~1,419.56 g/mol | | PubChem CID | 108101 | | Amino acid count | 15 | | Structure type | Linear (no disulfide bonds) | | Stability in gastric acid | >24 hours (in vitro) | | Half-life (IM/IV, animal models) | <30 minutes |
One of the more notable properties documented in preclinical research is its stability in gastric acid. Unlike many peptides that degrade rapidly in the gastrointestinal environment, BPC-157 has been shown to remain intact in human gastric juice for more than 24 hours in laboratory conditions. This stability has made it a subject of interest in oral administration models, in addition to injectable routes.
For research purposes, BPC-157 is produced synthetically through solid-phase peptide synthesis, which allows for precise control over amino acid sequencing and purity verification. The compound used in laboratory settings is not extracted from natural sources — it is manufactured to match the sequence identified in the naturally occurring gastric protein.
How BPC-157 Was Discovered
The discovery of BPC-157 came out of research into gastroprotective mechanisms — specifically, the study of how certain proteins in gastric juice protect the stomach lining from damage. Researchers identified a region of the parent protein that appeared particularly active in tissue-protective processes and isolated a 15-amino-acid fragment for further study.
What followed was decades of preclinical research in rodent models examining whether this fragment's cytoprotective properties extended beyond the gastrointestinal tract. Published studies from the Sikiric group and others explored its behavior in a range of biological systems, from musculoskeletal tissue to the central nervous system.
A 2025 literature and patent review published in *Pharmaceuticals* (MDPI) cataloged the compound's pleiotropic — meaning wide-ranging and multi-system — activity across numerous preclinical model types, describing it as one of the more comprehensively studied synthetic peptides in preclinical regenerative research.
Primary Mechanisms Studied in Preclinical Research
BPC-157 works through several interconnected biological pathways that have been characterized in animal and cell-based research. These are not confirmed mechanisms in humans — they represent findings from preclinical models.
VEGFR2 Pathway and Angiogenesis
The most extensively studied mechanism involves activation of the VEGFR2 (Vascular Endothelial Growth Factor Receptor 2) pathway. VEGF signaling drives angiogenesis — the formation of new blood vessels — which is a critical component of tissue repair in living organisms. In preclinical models, BPC-157 has been observed to stimulate this pathway, which researchers have proposed as one explanation for the tissue-repair-related findings seen in animal studies.
Nitric Oxide Signaling
BPC-157 interacts with nitric oxide synthase (NOS) in ways that have been documented in preclinical settings. Nitric oxide plays a dual role in biology — it can be cytoprotective at appropriate levels and cytotoxic in excess. Research into BPC-157's relationship with NO pathways has been an active area of investigation, with a 2025 commentary in *Pharmaceuticals* specifically addressing how the compound appears to modulate these competing functions in animal models.
FAK-Paxillin Pathway
Focal adhesion kinase (FAK) and paxillin are proteins involved in cell migration and adhesion — processes that are essential for wound healing because cells need to move into damaged areas and anchor to begin rebuilding tissue. Preclinical studies have documented activation of this complex in the presence of BPC-157.
JAK-2 Signaling
JAK-2 (Janus kinase 2) is a signaling protein that relays information from the cell surface to the nucleus, influencing cell survival, growth, and immune responses. Its activation has been observed in BPC-157 research models.
EGR-1 Gene Activation
Early Growth Response gene 1 (EGR-1) functions as a transcription factor — essentially a master switch that activates a broad array of genes involved in cell growth, survival, and blood vessel formation. Its upregulation has been documented in preclinical BPC-157 research.
ERK1/2 Pathway
The extracellular signal-regulated kinases (ERK1 and ERK2) are part of a signaling cascade involved in cell proliferation and differentiation. Their activation in response to BPC-157 has been reported in multiple preclinical studies.
> Explore research-grade BPC-157 with verified third-party COA documentation at Palmetto Peptides BPC-157 product page.
What Research Areas Has BPC-157 Been Studied In?
Preclinical research on BPC-157 has spanned a wide range of biological systems. The following is a summary of the primary research areas documented in the published literature — all in animal or cell-based models.
| Research Area | Model Type | Notes | |---|---|---| | Musculoskeletal tissue | Rodent | Tendon, ligament, muscle, bone models | | Gastrointestinal tract | Rodent | Mucosal protection, IBD, NSAID-injury models | | Central nervous system | Rodent | TBI, spinal cord, neurotransmitter pathways | | Cardiovascular | Rodent | Vascular and blood pressure models | | Wound healing | Rodent/in vitro | Skin, alkali-burn, and wound closure models |
A 2025 systematic review published in PMC analyzed 36 studies on BPC-157 from an orthopedic sports medicine perspective. Of those 36 studies, 35 were preclinical animal studies and 1 was a small, uncontrolled human case series. The reviewers concluded that while preclinical findings are extensive, human data remains insufficient to draw conclusions about safety or efficacy in people.
Is BPC-157 a Steroid?
No. BPC-157 is a peptide, not a steroid. Steroids are a class of lipid-based compounds with a characteristic four-ring molecular structure. BPC-157 is a short-chain amino acid sequence — structurally and mechanistically unrelated to any steroid compound. It does not interact with androgen receptors and is not classified as an anabolic agent.
Is BPC-157 Legal to Purchase for Research?
In the United States, BPC-157 is not a DEA-scheduled substance, meaning its possession is not illegal in the way that controlled substances like anabolic steroids are. It can be legally purchased as a research chemical for laboratory use.
However, the FDA classified BPC-157 as a Category 2 bulk drug substance in 2023, which prohibited compounding pharmacies from preparing it for patients. In February 2026, HHS Secretary Robert F. Kennedy Jr. announced a regulatory reversal that moved approximately 14 of the 19 previously restricted peptides — including BPC-157 — back toward Category 1 status, reopening the compounding pharmacy pathway.
For researchers purchasing BPC-157 through research chemical vendors, the compound remains legally available without a prescription for laboratory purposes. It is not, however, approved by any regulatory agency for human therapeutic use, and health authorities continue to caution against use outside of formal research settings.
> Palmetto Peptides supplies BPC-157 as a research compound only. View our third-party COA documentation and current inventory at Palmetto Peptides BPC-157.
What Form Does BPC-157 Come In for Research?
Research-grade BPC-157 is available in two primary forms:
Lyophilized powder is the standard and most widely used form. The peptide is freeze-dried and supplied in sterile vials. It is stable at room temperature during shipping and has a shelf life of 24 months or more when stored properly. Before use in laboratory protocols, it is reconstituted with bacteriostatic water. Oral/capsule form is used in research protocols where oral administration is specifically relevant — particularly studies related to gastrointestinal biology, given BPC-157's documented stability in gastric acid. Palmetto Peptides offers both forms for research purposes.When evaluating any BPC-157 source, researchers should look for third-party Certificate of Analysis (COA) documentation showing HPLC purity of 98% or higher and mass spectrometry confirmation of the correct molecular weight (~1,419 Da). In-house-only COAs are not sufficient for serious research work.
> Shop Palmetto Peptides' full BPC-157 catalog — lyophilized and oral forms available with batch-specific third-party COAs.
Summary
BPC-157 is a synthetic 15-amino-acid peptide derived from a protective protein in human gastric juice. It has been studied in preclinical research models for more than 30 years, with documented activity across multiple biological pathways including VEGFR2-mediated angiogenesis, nitric oxide signaling, and FAK-paxillin-driven cell migration. Its preclinical research profile spans musculoskeletal tissue, gastrointestinal biology, and the central nervous system, among other areas.
It is not FDA-approved for human use. Human clinical trial data remains extremely limited as of 2026. For researchers, it is legally available as a research compound, and its regulatory landscape shifted meaningfully in early 2026 following an HHS policy reversal on compounding restrictions.
Any BPC-157 sourced for research should come with verified third-party COA documentation confirming purity and molecular identity.
For qualified researchers, BPC-157 research peptide is available from Palmetto Peptides with full Certificate of Analysis documentation.
Frequently Asked Questions
What does BPC-157 stand for? BPC stands for Body Protection Compound. The 157 refers to its identity as the 157th fragment isolated from the parent gastric protein studied by researchers at the University of Zagreb. It is a synthetic pentadecapeptide — a chain of 15 amino acids. Is BPC-157 a natural or synthetic compound? Both, in a sense. The amino acid sequence originates from a naturally occurring protein found in human gastric juice. However, the BPC-157 used in laboratory research is produced entirely through synthetic solid-phase peptide synthesis — it is not extracted from biological tissue. This allows for precise quality control and purity verification. Is BPC-157 the same as a steroid? No. BPC-157 is a peptide, not a steroid. It has a completely different molecular structure, does not interact with androgen receptors, and is not classified as an anabolic agent by any regulatory body. Is BPC-157 approved by the FDA? No. As of 2026, BPC-157 is not approved by the FDA for any human therapeutic use. It was classified as a Category 2 bulk drug substance in 2023, which restricted compounding pharmacy access. A February 2026 HHS policy reversal has begun to change that landscape, but the compound remains unapproved for clinical use. What purity should research-grade BPC-157 have? Third-party COA documentation should confirm HPLC purity of 98% or higher and include mass spectrometry data confirming the correct molecular weight of approximately 1,419 daltons. In-house-only testing is not a reliable substitute for independent laboratory verification. Where can I purchase BPC-157 for research? Palmetto Peptides supplies research-grade BPC-157 in lyophilized and oral forms with batch-specific third-party COA documentation. Visit our BPC-157 product page for current inventory and pricing.References
- Sikiric P, et al. "Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract." *Current Pharmaceutical Design.* 2018;24(18):2002–2030. https://doi.org/10.2174/1381612824666180608101319
- Jozwiak M, Bauer M, Kamysz W, Kleczkowska P. "Multifunctionality and Possible Medical Application of the BPC 157 Peptide — Literature and Patent Review." *Pharmaceuticals.* 2025;18(2):185. https://doi.org/10.3390/ph18020185
- McGuire F, et al. "Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review." *PMC.* 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC12313605/
- Sikiric P, et al. "BPC 157 Therapy: Targeting Angiogenesis and Nitric Oxide's Cytotoxic and Damaging Actions." *Pharmaceuticals.* 2025;18(10):1450. https://doi.org/10.3390/ph18101450
- Wikipedia contributors. "BPC-157." *Wikipedia, The Free Encyclopedia.* Accessed March 2026. https://en.wikipedia.org/wiki/BPC-157
*Last updated: March 18, 2026* *Author: Palmetto Peptides Research Team* *For research use only. BPC-157 is not approved by the FDA for human use and is not intended for human consumption. All content on this page is for educational and scientific reference purposes only.*
Related Research
For research purposes only. Not intended for human or veterinary use. Palmetto Peptides supplies research-grade compounds exclusively for qualified laboratory and research professionals.